5442102026-10-125442102026-10-122026-10-125442102026-10-122026-10-12

AmalgamatedEntityDomain1

5442102026-10-12

AmalgamatedEntityDomain1

5442102026-10-122026-10-12

AmalgamatedEntityDomain2

5442102026-10-12

AmalgamatedEntityDomain2

5442102026-10-122026-10-12

AmalgamatedEntityDomain3

5442102026-10-12

AmalgamatedEntityDomain3

xbrli:purexbrli:shares

544210

Emcure Pharmaceuticals Limited

EMCURE

NOTLISTED

INE168P01015

New

Amalgamation/ Merger

true

2026-10-12

10:10:00

2026-10-12

Zuventus Healthcare Limited

Transferor

Material Subsidiary

Networth as on March 31, 2026 - Rs. 871.46 Crores Turnover for FY 2025-26 - Rs. 1,040.58 Crores

20055180

Emcutix Biopharmaceuticals Limited

Transferor

Subsidiary

Networth as on March 31, 2026 - Rs. (13.07) Crores Turnover for FY 2025-26 - Rs. 29.37 Crores

10000

Emcure Pharmaceuticals Limited

Transferee

Subsidiary

Networth as on March 31, 2026 - Rs. 3,710.60 Crores Turnover for FY 2025-26 - Rs. 5,243.19 Crores

147628200

0.7782

42082447

0.2218

189710647

147628200

0.7782

42082447

0.2218

189710647

false

true

The Company currently owns 100% shareholding in Zuventus Healthcare Limited ("Zuventus") and Emcutix Biopharmaceuticals Limited ("Emcutix"), Wholly owned Subsidiaries ("WOS" or "Transferor Companies") and therefore, related parties. Further, Promoters and Directors of the Company are also Director and Nominee Shareholders of the WOS. The relatives of such Directors who are Nominee Shareholders of WOS are also considered related parties.

true

Pharmaceutical

To achieve entity rationalization and operational efficiency within the group.

Others

No consideration shall be payable. The entire share capital of Transferor Companies is held by the Company and no shares shall be issued pursuant to the Scheme.

There will be no change in the shareholding pattern of the Company pursuant to the aforesaid Scheme, as no shares would be issued by the Company in consideration for the amalgamation.

Updates regarding the proposed Amalgamation shall be intimated to the stock exchanges, as and when required under the applicable regulations.